The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer

Clinical trial NCT06975384 · RECRUITING

Trial details

NCT number: NCT06975384
Sponsor: Second Xiangya Hospital of Central South University
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer Sleep Disturbance Immune Checkpoint Inhibitors Cancer, Treatment-Related

Start date: 2024-11-01
Primary completion: 2029-12-31
Enrollment: 1270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.